WHO ICTRP trial
The use of Nisha Aamlaki Powder and Brahmi Powder, combined with walking, to…
CTRI/2025/07/090043 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/07/090043 |
|---|---|
| Public title | The use of Nisha Aamlaki Powder and Brahmi Powder, combined with walking, to manage Type 2 Diabetes. |
| Scientific title | Efficacy of Nisha Aamlaki Churna and Brahmi Churna along with Chankraman in the management of Madhumeha (Type 2 Diabetes) An open randomized Comparative clinical Study. - NIL |
| Primary sponsor | FIMS SGT University |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: E119- Type 2 diabetes mellitus without complications |
| Interventions | Intervention1: Nisha Aamlaki Churna : 5 Grams, oral route, Two times ( Morning and Evening) For 10 weeks. Control Intervention1: Brahmi churna: 5 Grams, oral route, Two times ( Morning and Evening) For 10 weeks. |
| Registration date | Feb 7, 2025 |
| Target size | 200 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: